Alcohol Withdrawal Syndrome
📧 Sign up to get email alerts when something new happens for Alcohol Withdrawal Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: tAN for Substance Use Disorder [NA]
A clinical trial update indicates that tAN is being studied for alcohol use disorder and related substance use disorders, and the study is c…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving [Phase 2, Phase 3]
Cannabidiol is being studied as an adjunct treatment for alcohol use disorder, including withdrawal and craving, in Phase 2 and Phase 3 tria…
-
FDA approval · 2025-11-14FDA Approved: DIAZEPAM — Original Application (Navinta LLC)
FDA approved Navinta LLC's generic diazepam through an Original Application (ANDA 217468).
-
EMA other · 2025-06-20EMA starts review of sodium oxybate in alcohol dependence
EMA has initiated a review of sodium oxybate for alcohol dependence to assess its effectiveness in treating alcohol withdrawal and supportin…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
This clinical trial update reports validation of the French version of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) for indiv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-12-17FDA Approved: DIAZEPAM — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for diazepam submitted by Lupin Pharmaceuticals, Inc. The approval relates to changes under the appr…
-
FDA approval · 2024-12-16FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc., updating the approval status of this generic produ…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients
The document reports a clinical trial studying the impact of clinical and biochemical variables on morbidity and mortality in alcohol withdr…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Evaluation of a Predictive Score for the Onset of Moderate to Severe Alcohol Withdrawal Syndrome, the PAWSS, in a Population of Intensive Care Patients at Brest University Hospital
This completed clinical trial evaluates the PAWSS predictive score for onset of moderate to severe alcohol withdrawal syndrome in intensive …
-
FDA approval · 2024-07-18FDA Approved: DIAZEPAM — Original Application (Dr. Reddy's Laboratories Inc)
FDA approves the Diazepam original application for Dr. Reddy's Laboratories Inc, establishing a generic Diazepam product in the U.S. underAN…
-
FDA approval · 2024-04-25FDA Approved: DIAZEPAM — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's original application for a generic diazepam product. This approval supports a generic version…
-
FDA approval · 2023-11-22FDA Approved: DIAZEPAM — Supplemental Application (Sunrise Pharmaceutical, Inc.)
The FDA approved a supplemental application for Diazepam submitted by Sunrise Pharmaceutical, Inc.
-
FDA approval · 2023-10-11FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)
FDA approved a Supplemental Application for Valium (diazepam) from Roche Laboratories Inc., indicating an approved change or addition to the…
-
FDA approval · 2023-07-10FDA Approved: DIAZEPAM — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for Diazepam from Oceanside Pharmaceuticals.
-
FDA approval · 2023-04-25FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for diazepam (generic) under ANDA 071583. This represents a supplemental approval for a gene…
-
FDA approval · 2023-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved Natco Pharma USA LLC's supplemental application for Diazepam (generic) under ANDA210363. This approval advances the generic Dia…
-
FDA approval · 2023-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approves a supplemental application for Diazepam by Natco Pharma USA LLC, approving a supplemental change to the generic diazepam produc…
-
FDA approval · 2023-01-17FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for chlordiazepoxide hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam submitted by Hikma Pharmaceuticals USA Inc., marking regulatory action to support t…
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for diazepam oral solution concentrate from Chartwell RX, LLC, adding/confirming approval for this d…
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Diazepam from Hikma Pharmaceuticals USA Inc., indicating an update to an existing Diazepam produ…
-
FDA approval · 2023-01-13FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)
The FDA approved a supplemental application for Valium (diazepam) from Roche Laboratories Inc., updating the existing NDA.
-
FDA approval · 2023-01-11FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for diazepam (generic) from Natco Pharma USA LLC under ANDA210363.
-
FDA approval · 2022-11-10FDA Approved: DIAZEPAM — Original Application (Fresenius Kabi USA, LLC)
The FDA approved Fresenius Kabi USA, LLC's Original Application for diazepam (generic diazepam). This approval adds a new generic option for…
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Gabapentin for Alcohol Withdrawal Syndrome [Phase 4]
Phase 4 trial investigating gabapentin for Alcohol Withdrawal Syndrome completed with results posted in 2022.